Pfe Stock Price Target

50 Day Moving Average is the resistance level 3939. This rating represents a strong Buy recommendation on the scale.

Xanegczzq Zmnm

Today 200 Day Moving Average is the support level 3725.

Pfe stock price target. Pfizer PFE closed at 3976 in the latest trading session marking a 038 move from the prior day. Spread Average Target. Analysis on target price and performance of stocks is usually carefully studied by market experts and the current Wall Street consensus on PFE stock is a recommendation set at 260.

Pfizers target price is an analysts projection of its future price. What You Should Know. 307 Zeilen 13 Wall Street analysts have set twelve-month price targets for Pfizer in the last year.

Facebook FB Outpaces Stock. The new note on the price target was released on April 07 2021 representing the official price target for Pfizer Inc. 10 Wall Street analysts that have issued a 1 year PFE price target the average PFE price target is 4240 with the highest PFE stock price forecast at 4900 and the lowest PFE stock price forecast at 3900.

Price targets can be assigned to all types of securities from complex investment products to stocks such as Pfizer Inc and even bonds. 19 analyst firms have reported ratings in the last year. When setting a price target estimate an analyst is trying to determine what the Stock.

Price Target UpsideDownside According to analysts consensus price target of 4169 Pfizer has a forecasted upside of 50 from its current price of 3969. The analyst firm set a price target for 4300 expecting PFE to fall to within 12 months a possible -1392 downside. Get NYE PFE Pfizer Inc latest stock price analyst ratings fundamental analysis ratios market performance news target price and financial report.

PFE Stock-Pfizer Inc Stock Breaking News Today Pfizer Stock Price Prediction Pfizer Stock Target. To date analysts have a 4297 target price for Pfizer stock stock. The rating they have provided for PFE stocks is Neutral according to the report published on May 06th 2021.

On December 16 2020 analysts decreased their price target for PFE shares from 43 to 42. Pfizer PFE Outpaces Stock Market Gains. Amount of Analyst Coverage Pfizer has been the subject of 8 research reports in the past 90 days demonstrating strong analyst interest in this stock.

PFE updated stock price target summary. Previously the target price had yet another raise to 41 while DZ Bank analysts kept a Buy rating on PFE stock. RBC Capital Mkts gave a rating of Sector Perform to PFE setting the target price at 42 in the report published on April 07th of the current year.

The average price target represents a -557 change from the last price of 4880. Analyst ratings historical stock prices earnings estimates actuals. According to analyst projections PFEs forecast low is 3900 with 6100 as the target high.

The average price target is 4608 with a high forecast of 6100 and a low forecast of 4000. 30 Zeilen Pfizer NYSEPFE Price Target and Consensus Rating 13 Wall Street analysts have issued ratings and price targets for Pfizer in the last 12 months. To hit the forecast high the stocks price needs a -221 plunge from its current level while the stock would need to tank 2194 for it.

Based on 12 Wall Street analysts offering 12 month price targets for Pfizer in the last 3 months. If the target price is unavailable it is most likely because there were not enough analyst opinions to come up with a consensus estimate. Based on careful and fact-backed analyses by Wall Street experts the current consensus on the target price for PFE shares is 4297 per share.

40 Zeilen The upside potential average analyst target price relative to current price of PFE is. Their average twelve-month price target is 4169 predicting that the stock has a possible upside of 486. The consensus price target for the stock as assigned by Wall Street analysts is 4485 meaning bulls need a downside of -1139 from its recent market value.

The high price target for PFE is 4500 and the low price target for PFE is 3900.

Could This Little Known Company S Vaccine Candidate Leapfrog Moderna And Pfizer Nasdaq